livehealth.store

BE Pharmaceuticals recalls

BE Pharmaceuticals has 2 recalls on record with the FDA and USDA, the earliest in 2023 and the latest reported on 31 Jan 2024. The most frequent reason is sterility.

Total recalls2since 2023

Last 12 months0reported

Class I00% of total

Ongoing0latest 31 Jan 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why be pharmaceuticals is recalled

Sterility2100%

Product types

Brands

Fosaprepitant150%
Pantoprazole Sodium150%

By year

2024150%
2023150%

All be pharmaceuticals recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
31 Jan 2024Drug	CLASS II	Fosaprepitant for Injection 150 mg per vial recalledFosaprepitant	BE Pharmaceuticals	Sterility	Nationwide
20 Sep 2023Drug	CLASS II	Pantoprazole Sodium for Injection 40mg per vial, Single dose vials recalledPantoprazole Sodium	BE Pharmaceuticals	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.